Bright Green Corporation (BGXX)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 201.78 Thousand USD | -94.53% |
| 2022 | 3.68 Million USD | 839.87% |
| 2021 | 392.19 Thousand USD | 2.51% |
| 2020 | 382.6 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | -100.0% |
| 2024 Q1 | 166.23 Thousand USD | -17.62% |
| 2023 Q3 | - USD | -100.0% |
| 2023 FY | 201.78 Thousand USD | -94.53% |
| 2023 Q4 | 201.78 Thousand USD | 0.0% |
| 2023 Q2 | 3.56 Million USD | 2.94% |
| 2023 Q1 | 3.46 Million USD | -6.13% |
| 2022 Q2 | 2 Million USD | 0.0% |
| 2022 Q1 | - USD | -100.0% |
| 2022 FY | 3.68 Million USD | 839.87% |
| 2022 Q4 | 3.68 Million USD | 81.18% |
| 2022 Q3 | 2.03 Million USD | 1.48% |
| 2021 FY | 392.19 Thousand USD | 2.51% |
| 2021 Q2 | 393.89 Thousand USD | 0.0% |
| 2021 Q4 | 392.19 Thousand USD | 19.8% |
| 2021 Q3 | 327.36 Thousand USD | -16.89% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q4 | 382.6 Thousand USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 382.6 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 99.935% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 99.778% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 99.959% |
| Cosmos Health Inc. | 3.03 Million USD | 93.352% |
| Dynavax Technologies Corporation | 252.41 Million USD | 99.92% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | 98.486% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 99.961% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | 62.566% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | 62.566% |
| SCYNEXIS, Inc. | 12.15 Million USD | 98.34% |
| Safety Shot Inc | 304.9 Thousand USD | 33.821% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -72.274% |
| Alpha Teknova, Inc. | 13.25 Million USD | 98.477% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 99.96% |
| Embecta Corp. | 1.62 Billion USD | 99.988% |
| PainReform Ltd. | 30 Thousand USD | -572.61% |
| Journey Medical Corporation | 14.62 Million USD | 98.62% |
| Procaps Group, S.A. | 28.41 Million USD | 99.29% |
| Theratechnologies Inc. | 51.26 Million USD | 99.606% |
| Harrow Health, Inc. | 183.17 Million USD | 99.89% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -131.934% |
| Biofrontera Inc. | 804 Thousand USD | 74.903% |
| DURECT Corporation | 2.7 Million USD | 92.532% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 99.392% |
| Cronos Group Inc. | 1.55 Million USD | 87.057% |
| OptiNose, Inc. | 611 Thousand USD | 66.975% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 99.96% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | 99.41% |
| RedHill Biopharma Ltd. | 455 Thousand USD | 55.652% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 99.668% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 98.422% |
| Radius Health, Inc. | 339.66 Million USD | 99.941% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | 98.033% |
| Phibro Animal Health Corporation | 458.28 Million USD | 99.956% |
| Procaps Group S.A. | 28.41 Million USD | 99.29% |
| Alvotech | 1.02 Billion USD | 99.98% |
| TherapeuticsMD, Inc. | 6.53 Million USD | 96.911% |
| Viatris Inc. | 16.18 Billion USD | 99.999% |
| Rockwell Medical, Inc. | 8.29 Million USD | 97.567% |
| Aytu BioPharma, Inc. | 10.87 Million USD | 98.145% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | 39.944% |
| Tilray Brands, Inc. | 287.93 Million USD | 99.93% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 99.833% |
| Shineco, Inc. | 10.01 Million USD | 97.986% |
| PetIQ, Inc. | 437.82 Million USD | 99.954% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | 3.913% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 99.922% |
| Alimera Sciences, Inc. | 64.48 Million USD | 99.687% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | 99.476% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -49.37% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | 97.057% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | 71.975% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -797.452% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | 99.384% |
| Hempacco Co., Inc. | 5.93 Million USD | 96.598% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 99.98% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 99.641% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 99.967% |
| Currenc Group, Inc. | 2.5 Million USD | 91.951% |
| Kamada Ltd. | 7.43 Million USD | 97.287% |
| Indivior PLC | 235.66 Million USD | 99.914% |
| Evoke Pharma, Inc. | 5 Million USD | 95.964% |
| Flora Growth Corp. | 942 Thousand USD | 78.579% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -797.452% |
| Evolus, Inc. | 120.35 Million USD | 99.832% |
| HUTCHMED (China) Limited | 48.18 Million USD | 99.581% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 99.966% |
| Akanda Corp. | 2.49 Million USD | 91.919% |